Literature DB >> 9573121

Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis.

N Zantl1, A Uebe, B Neumann, H Wagner, J R Siewert, B Holzmann, C D Heidecke, K Pfeffer.   

Abstract

Despite considerable progress, peritonitis and sepsis remain life-threatening conditions. To improve the understanding of the pathophysiology encountered in sepsis, a new standardized and highly reproducible murine model of abdominal sepsis termed colon ascendens stent peritonitis (CASP) was developed. In CASP, a stent is inserted into the ascending colon, which generates a septic focus. CASP employing a stent of 14-gauge diameter (14G stent) results in a mortality of 100% within 18 to 48 h after surgery. By inserting stents of small diameters, mortality can be exactly controlled. Thus, CASP surgery with insertion of a 22G or 18G stent (22G or 18G CASP surgery) results in 38 or 68% mortality, respectively. 14G CASP surgery leads to a rapid invasion of bacteria into the peritoneum and the blood. As a consequence, endotoxemia occurs, inflammatory cells are recruited, and a systemic inflammatory response syndrome develops. Interestingly, the most pronounced upregulation of inflammatory cytokines (gamma interferon [IFN-gamma], tumor necrosis factor alpha [TNF-alpha] and interleukin-12) is observed in spleen and lungs. CASP surgery followed by stent removal at specific time intervals revealed that all animals survived if intervention was performed after 3 h, whereas removal of the septic focus after 9 h did not prevent death, suggesting induction of autonomous mechanisms of a lethal inflammatory response syndrome. 18G CASP surgery in IFN-gamma receptor-deficient (IFNgammaR-/-) mice revealed an essential role of IFN-gamma in survival of sepsis, whereas TNF receptor p55-deficient (TNFRp55-/-) mice did not show altered survival rates. In summary, this study describes a novel animal model that closely mimics human sepsis and appears to be highly suitable for the study of the pathophysiology of abdominal sepsis. Importantly, this model demonstrates a protective role of IFN-gamma in survival of bacterial sepsis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573121      PMCID: PMC108195          DOI: 10.1128/IAI.66.5.2300-2309.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

Review 1.  Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification.

Authors:  E T Rietschel; H Brade; O Holst; L Brade; S Müller-Loennies; U Mamat; U Zähringer; F Beckmann; U Seydel; K Brandenburg; A J Ulmer; T Mattern; H Heine; J Schletter; H Loppnow; U Schönbeck; H D Flad; S Hauschildt; U F Schade; F Di Padova; S Kusumoto; R R Schumann
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

Review 2.  Conditional gene targeting.

Authors:  K Rajewsky; H Gu; R Kühn; U A Betz; W Müller; J Roes; F Schwenk
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 3.  Applied molecular biology of sepsis.

Authors:  D G Remick
Journal:  J Crit Care       Date:  1995-12       Impact factor: 3.425

4.  Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury.

Authors:  C O'Suilleabhain; S T O'Sullivan; J L Kelly; J Lederer; J A Mannick; M L Rodrick
Journal:  Surgery       Date:  1996-08       Impact factor: 3.982

Review 5.  Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

Review 6.  Immune defence in mice lacking type I and/or type II interferon receptors.

Authors:  M F van den Broek; U Müller; S Huang; R M Zinkernagel; M Aguet
Journal:  Immunol Rev       Date:  1995-12       Impact factor: 12.988

7.  Critical protective role of mast cells in a model of acute septic peritonitis.

Authors:  B Echtenacher; D N Männel; L Hültner
Journal:  Nature       Date:  1996-05-02       Impact factor: 49.962

Review 8.  The sepsis syndrome. Definition and general approach to management.

Authors:  R C Bone
Journal:  Clin Chest Med       Date:  1996-06       Impact factor: 2.878

9.  Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.

Authors:  C J Fisher; J M Agosti; S M Opal; S F Lowry; R A Balk; J C Sadoff; E Abraham; R M Schein; E Benjamin
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

View more
  70 in total

Review 1.  Differential Paradigms in Animal Models of Sepsis.

Authors:  S Manoj Kumar Kingsley; B Vishnu Bhat
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

Review 2.  Modeling sepsis in the laboratory: merging sound science with animal well-being.

Authors:  Jean A Nemzek; Kelly M S Hugunin; Mark R Opp
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

3.  Implantation of alloplastic material increases survival of mice subsequently exposed to polymicrobial sepsis.

Authors:  Wolfram Kessler; Tobias Ebker; Pia Koerner; Christian Poetschke; Katharina Cziupka; Tobias Traeger; Alexandra Westerholt; Hendrik Mehmcke; Friederike Neher; Robert S Jack; Claus-Dieter Heidecke; Stefan Maier
Journal:  Langenbecks Arch Surg       Date:  2009-01-27       Impact factor: 3.445

Review 4.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.

Authors:  Thomas Hehlgans; Klaus Pfeffer
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

Review 5.  Peritoneal damage: the inflammatory response and clinical implications of the neuro-immuno-humoral axis.

Authors:  Tarik Sammour; Arman Kahokehr; Mattias Soop; Andrew G Hill
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

Review 6.  [Pathophysiological basis of surgery-linked sepsis].

Authors:  B Vollmar
Journal:  Chirurg       Date:  2011-03       Impact factor: 0.955

Review 7.  Murine Models of Sepsis and Trauma: Can We Bridge the Gap?

Authors:  Julie A Stortz; Steven L Raymond; Juan C Mira; Lyle L Moldawer; Alicia M Mohr; Philip A Efron
Journal:  ILAR J       Date:  2017-07-01

Review 8.  Bench-to-Bedside: A Translational Perspective on Murine Models of Sepsis.

Authors:  Anthony J Lewis; Matthew R Rosengart
Journal:  Surg Infect (Larchmt)       Date:  2018-02-02       Impact factor: 2.150

9.  Impact of interleukin-12, oxidative burst, and iNOS on the survival of murine fecal peritonitis.

Authors:  Markus Entleutner; Tobias Traeger; Alexandra Westerholt; Bernhard Holzmann; Albrecht Stier; Klaus Pfeffer; Stefan Maier; Claus-Dieter Heidecke
Journal:  Int J Colorectal Dis       Date:  2005-03-09       Impact factor: 2.571

10.  Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis.

Authors:  Richard S Hotchkiss; Katherine C Chang; Mitchell H Grayson; Kevin W Tinsley; Benjamin S Dunne; Christopher G Davis; Dale F Osborne; Irene E Karl
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.